Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Capecitabine
Xelox
Routinely available
Local application
29/03/2023
Indication
In combination with epirubicin and cisplatin (ECX) for palliative treatment of advanced oesphagogastric cancer
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available
Formulation
-
Comments
-